Mm. Behrens et al., Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: Blockade of p38 mitogen-activated protein kinase, NEUROSCIENC, 94(3), 1999, pp. 917-927
Consistent with previous studies on cell lines and non-neuronal cells, spec
ific inhibitors of protein kinase C induced mouse primary cultured neocorti
cal neurons to undergo apoptosis. To examine the complementary hypothesis t
hat activating protein kinase C would attenuate neuronal apoptosis, the cul
tures were exposed for Ih to phorbol-12-myristare-13-acetate, which activat
ed protein kinase C as evidenced by downstream enhancement of the mitogen-a
ctivated protein kinase pathway. Exposure to phorbol-12-myristate-13-acetat
e, or another active phorbol ester, phorbol-12,13-didecanoate, but not to t
he inactive ester, 4 alpha-phorbol-12,13-didecanoate, markedly attenuated n
euronal apoptosis induced by serum deprivation. Phorbol-12-myristate-13-ace
tate also attenuated neuronal apoptosis induced by exposure to beta-amyloid
peptide 1-42, or oxygen-glucose deprivation in the presence of glutamate r
eceptor antagonists.
The neuroprotective effects of phorbol-12-myristate-13-acetate were blocked
by brief (non-toxic) concurrent exposure to the specific protein kinase C
inhibitors, but not by a specific mitogen-activated protein kinase I inhibi
tor. Phorbol-12-myristate-13-acetate blocked the induction of p38 mitogen-a
ctivated protein kinase activity and specific inhibition of this kinase by
SE 203580 attenuated serum deprivation-induced apoptosis. c-Jun N-terminal
kinase 1 activity was high at rest and not modified by phorbol-12-myristate
-13-acetate treatment. These data strengthen the idea that protein kinase C
is a key modulator of several forms of central neuronal apoptosis, in part
acting through inhibition of p38 mitogen-activated protein kinase regulate
d pathways. (C) 1999 IBRO. Published by Elsevier Science Ltd.